Overview

A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

Status:
Recruiting

Trial end date:
2025-03-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of redasemtide in adult participants with acute ischemic stroke (AIS).

Phase:

Phase 2

Details

Lead Sponsor:

Shionogi